{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:07:56Z","timestamp":1790680076403,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.molstruc.2021.130409","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T17:22:03Z","timestamp":1617729723000},"page":"130409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19"],"prefix":"10.1016","volume":"1237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-4041","authenticated-orcid":false,"given":"Vahid","family":"Zarezade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghodratollah","family":"Shakerinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Safavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Nazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Veisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Azadbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Sabaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Shajirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10229","key":"10.1016\/j.molstruc.2021.130409_bib0001","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(20)30553-5","article-title":"Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries","volume":"395","author":"Kandel","year":"2020","journal-title":"Lancet North Am. Ed."},{"issue":"7798","key":"10.1016\/j.molstruc.2021.130409_bib0002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molstruc.2021.130409_bib0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.molstruc.2021.130409_bib0004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"issue":"6483","key":"10.1016\/j.molstruc.2021.130409_bib0006","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.molstruc.2021.130409_bib0007","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1016\/j.molstruc.2021.130409_bib0008","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JVI.02744-05","article-title":"Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.molstruc.2021.130409_bib0009","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0011","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.molstruc.2021.130409_bib0012","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10096-020-03883-y","article-title":"Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV","volume":"39","author":"Li","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.molstruc.2021.130409_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0014-5793(03)01091-3","article-title":"Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes","volume":"553","author":"Gao","year":"2003","journal-title":"FEBS Lett."},{"issue":"7811","key":"10.1016\/j.molstruc.2021.130409_bib0014","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"6489","key":"10.1016\/j.molstruc.2021.130409_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molstruc.2021.130409_bib0016","article-title":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation","author":"Xu","year":"2020","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.molstruc.2021.130409_bib0017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130409_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.molstruc.2021.130409_bib0019","article-title":"Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3\u2005Billion Compounds","author":"Ton","year":"2021","journal-title":"Mol Inform"},{"issue":"1","key":"10.1016\/j.molstruc.2021.130409_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: a systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0021","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/acs.jproteome.0c00686","article-title":"ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2","volume":"20","author":"Panda","year":"2021","journal-title":"J. Proteome Res."},{"issue":"40","key":"10.1016\/j.molstruc.2021.130409_bib0022","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0023","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bmcl.2007.11.048","article-title":"Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite","volume":"18","author":"Deaton","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.molstruc.2021.130409_bib0024","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/jm701275z","article-title":"Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2","volume":"51","author":"Mores","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.130409_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.phymed.2017.11.012","article-title":"Predicting tyrosinase inhibition by 3D QSAR pharmacophore models and designing potential tyrosinase inhibitors from Traditional Chinese medicine database","volume":"38","author":"Gao","year":"2018","journal-title":"Phytomedicine"},{"issue":"D1","key":"10.1016\/j.molstruc.2021.130409_bib0026","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130409_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/jm010360c","article-title":"Pharmacophore Mapping of a Series of 2,4-Diamino-5-deazapteridine Inhibitors of Mycobacterium avium Complex Dihydrofolate Reductase","volume":"45","author":"Debnath","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.130409_bib0028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.compbiolchem.2018.04.002","article-title":"Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches","volume":"74","author":"Rampogu","year":"2018","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.molstruc.2021.130409_bib0029","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","article-title":"Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors","volume":"17","author":"Pal","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"issue":"18","key":"10.1016\/j.molstruc.2021.130409_bib0030","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1080\/07391102.2018.1559098","article-title":"Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7","volume":"37","author":"Gupta","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"D1","key":"10.1016\/j.molstruc.2021.130409_bib0031","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130409_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u00a0\u2212\u00a0A Free Database of Commercially Available Compounds for Virtual Screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10.1016\/j.molstruc.2021.130409_bib0033","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discovery Today: Technologies"},{"issue":"W1","key":"10.1016\/j.molstruc.2021.130409_bib0034","doi-asserted-by":"crossref","first-page":"W200","DOI":"10.1093\/nar\/gkv353","article-title":"FAF-Drugs3: a web server for compound property calculation and chemical library design","volume":"43","author":"Lagorce","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molstruc.2021.130409_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.phymed.2018.09.199","article-title":"Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease","volume":"54","author":"Jiang","year":"2019","journal-title":"Phytomedicine"},{"issue":"1\u20132","key":"10.1016\/j.molstruc.2021.130409_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0037","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"issue":"9","key":"10.1016\/j.molstruc.2021.130409_bib0038","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"issue":"16","key":"10.1016\/j.molstruc.2021.130409_bib0039","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"issue":"12","key":"10.1016\/j.molstruc.2021.130409_bib0040","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"},{"issue":"8","key":"10.1016\/j.molstruc.2021.130409_bib0041","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J Comput Chem"},{"issue":"12","key":"10.1016\/j.molstruc.2021.130409_bib0042","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"issue":"12","key":"10.1016\/j.molstruc.2021.130409_bib0043","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"issue":"5","key":"10.1016\/j.molstruc.2021.130409_bib0044","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"7)","key":"10.1016\/j.molstruc.2021.130409_bib0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"Journal of Chemical Information and Modeling,"},{"issue":"12","key":"10.1016\/j.molstruc.2021.130409_bib0046","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00894-018-3858-6","article-title":"In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment","volume":"24","author":"Zarezade","year":"2018","journal-title":"J Mol Model"},{"issue":"5","key":"10.1016\/j.molstruc.2021.130409_bib0047","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1002\/jcb.28013","article-title":"Pyrazinamide drug resistance in RpsA mutant (\u2206438A) of Mycobacterium tuberculosis: dynamics of essential motions and free-energy landscape analysis","volume":"120","author":"Singh","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molstruc.2021.130409_bib0048","first-page":"1","article-title":"Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM\/MM affinity estimation","author":"Bharadwaj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiolchem.2018.01.005","article-title":"3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B","volume":"73","author":"Ma","year":"2018","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.molstruc.2021.130409_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128595","article-title":"Inhibitory activity of hydroxychloroquine on COVID-19 main protease: an insight from MD-simulation studies","volume":"1219","author":"Baildya","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.molstruc.2021.130409_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106012","article-title":"Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking","author":"Yu","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.molstruc.2021.130409_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","author":"Tahir ul Qamar","year":"2020","journal-title":"J Pharm Anal"},{"issue":"2","key":"10.1016\/j.molstruc.2021.130409_bib0053","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/ci800293n","article-title":"Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase","volume":"49","author":"Hevener","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.molstruc.2021.130409_bib0054","series-title":"An Introduction to Hydrogen Bonding","author":"Jeffrey","year":"1997"},{"issue":"17","key":"10.1016\/j.molstruc.2021.130409_bib0055","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molstruc.2021.130409_bib0056","first-page":"1","article-title":"An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease","author":"Havranek","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0057","first-page":"1","article-title":"Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach","author":"Alagu Lakshmi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0058","first-page":"1","article-title":"Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0059","first-page":"1","article-title":"Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach","author":"Mittal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0060","first-page":"1","article-title":"Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0061","first-page":"1","article-title":"Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130409_bib0062","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.molstruc.2018.08.029","article-title":"Investigating the binding mechanism of (4-Cyanophenyl)glycine derivatives as reversible LSD1 by 3D-QSAR, molecular docking and molecular dynamics simulations","volume":"1175","author":"Wang","year":"2019","journal-title":"J Mol Struct"},{"issue":"16","key":"10.1016\/j.molstruc.2021.130409_bib0063","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.molstruc.2021.130409_bib0064","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1039\/D0FO00003E","article-title":"Inhibitory mechanism of epicatechin gallate on tyrosinase: inhibitory interaction, conformational change and computational simulation","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct"},{"issue":"19","key":"10.1016\/j.molstruc.2021.130409_bib0065","doi-asserted-by":"crossref","first-page":"10550","DOI":"10.1021\/acs.jpcc.0c01220","article-title":"Enabling Efficient and Accurate Computational Studies of MOF Reactivity via QM\/MM and QM\/QM Methods","volume":"124","author":"Cui","year":"2020","journal-title":"The Journal of Physical Chemistry C"},{"issue":"12","key":"10.1016\/j.molstruc.2021.130409_bib0066","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.3390\/ijms12129236","article-title":"3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase Inhibitors","volume":"12","author":"Arooj","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molstruc.2021.130409_bib0067","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.micpath.2016.12.003","article-title":"Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation","volume":"103","author":"Rajamanikandan","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molstruc.2021.130409_bib0068","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mehy.2018.01.004","article-title":"Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies","volume":"112","author":"Ardalan","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.molstruc.2021.130409_bib0069","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.compbiolchem.2018.08.005","article-title":"Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: a combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses","volume":"77","author":"Mohseni","year":"2018","journal-title":"Comput Biol Chem"}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021005421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021005421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:51:42Z","timestamp":1762671102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286021005421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":69,"alternative-id":["S0022286021005421"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.130409","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.130409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130409"}}